The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery

NCT01683448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2020-12-03

No results posted yet for this study

Summary

This study will be a retrospective study. The patient data from the electronic medical records and existing database will be collected and analyzed. Primary endpoints will be postoperative mortality (within 30 days) and overall complications and length of hospital stay. The secondary endpoints will be myocardial infarction, cardiac death, CHF, arrhythmia, ischemia, stroke, neurological complications, length of ICU stay, re-admission rate, infections, pulmonary complications, length of intubation time, length of ventilation time, and acute renal failure.

Conditions

  • Cardiac Diseases

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Hong Liu, M.D. · UC Davis, Department of Anesthesiology and Pain Medicine

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01683448 on ClinicalTrials.gov